Related references
Note: Only part of the references are listed.Dose-Dependent Solubility-Permeability Interplay for Poorly Soluble Drugs under Non-Sink Conditions
Kazuya Sugita et al.
PHARMACEUTICS (2021)
In vitro dissolution considerations associated with nano drug delivery systems
Ritu Gupta et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2021)
The elucidation of key factors for oral absorption enhancement of nanocrystal formulations: In vitro-in vivo correlation of nanocrystals
Masaaki Imono et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2020)
On the Usefulness of Two Small-Scale In Vitro Setups in the Evaluation of Luminal Precipitation of Lipophilic Weak Bases in Early Formulation Development
Patrick J. O'Dwyer et al.
PHARMACEUTICS (2020)
Six years of progress in the oral biopharmaceutics area - A summary from the IMI OrBiTo project
B. Abrahamsson et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2020)
Intestinal absorption of BCS class II drugs administered as nanoparticles: A review based on in vivo data from intestinal perfusion models
David Dahlgren et al.
ADMET AND DMPK (2020)
Evaluation of improved oral bioavailability of ritonavir nanosuspension
Alptug Karakucuk et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Sustained release and improved bioavailability in mice after subcutaneous administration of griseofulvin as nano- and microcrystals
Kalle Sigfridsson et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems
Ben J. Boyd et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Application of a Refined Developability Classification System
Julian Rosenberger et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
A Refined Developability Classification System
Julian Rosenberger et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Ranking Itraconazole Formulations Based on the Flux through Artificial Lipophilic Membrane
Konstantin Tsinman et al.
PHARMACEUTICAL RESEARCH (2018)
Jejunal absorption of aprepitant from nanosuspensions: Role of particle size, prandial state and mucus layer
C. Roos et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)
In Vivo Predictive Dissolution (IPD) and Biopharmaceutical Modeling and Simulation: Future Use of Modern Approaches and Methodologies in a Regulatory Context
H. Lennernas et al.
MOLECULAR PHARMACEUTICS (2017)
Utilizing In Vitro Dissolution-Permeation Chamber for the Quantitative Prediction of pH-Dependent Drug-Drug Interactions with Acid-Reducing Agents: a Comparison with Physiologically Based Pharmacokinetic Modeling
Andy Z. X. Zhu et al.
AAPS JOURNAL (2016)
A Review: Pharmaceutical and Pharmacokinetic Aspect of Nanocrystalline Suspensions
Dhaval A. Shah et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Impact of Nanosizing on Solubility and Dissolution Rate of Poorly Soluble Pharmaceuticals
Sharad B. Murdande et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates
Bradley Croy Doak et al.
CHEMISTRY & BIOLOGY (2014)
Oral biopharmaceutics tools - Time for a new initiative - An introduction to the IMI project OrBiTo
H. Lennernas et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
In vitro models for the prediction of in vivo performance of oral dosage forms
Edmund S. Kostewicz et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
The Biopharmaceutics Classification System: Subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC
Yasuhiro Tsume et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Strategies to Address Low Drug Solubility in Discovery and Development
Hywel D. Williams et al.
PHARMACOLOGICAL REVIEWS (2013)
Crystalline Nanosuspensions as Potential Toxicology and Clinical Oral Formulations for BCS II/IV Compounds
Filippos Kesisoglou et al.
AAPS JOURNAL (2012)
Analytical methods for dissolution testing of nanosized drugs
Daniel Juenemann et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2012)
Biorelevant in vitro dissolution testing of products containing micronized or nanosized fenofibrate with a view to predicting plasma profiles
Daniel Juenemann et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2011)
Lipophilicity and Its Relationship with Passive Drug Permeation
Xiangli Liu et al.
PHARMACEUTICAL RESEARCH (2011)
Possible reduction of effective thickness of intestinal unstirred water layer by particle drifting effect
Kiyohiko Sugano
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
The Developability Classification System: Application of Biopharmaceutics Concepts to Formulation Development
James M. Butler et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Aqueous Boundary Layers Related to Oral Absorption of a Drug: From Dissolution of a Drug to Carrier Mediated Transport and Intestinal Wall Metabolism
Kiyohiko Sugano
MOLECULAR PHARMACEUTICS (2010)
Effect of Crystal Size on the In Vitro Dissolution and Oral Absorption of Nitrendipine in Rats
Dengning Xia et al.
PHARMACEUTICAL RESEARCH (2010)
Leakiness and Size Exclusion of Paracellular Channels in Cultured Epithelial Cell Monolayers-Interlaboratory Comparison
Alex Avdeef
PHARMACEUTICAL RESEARCH (2010)
Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors
Hany S. M. Ali et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Rapid throughput solubility screening method for BCS class II drugs in animal GI fluids and simulated human GI fluids using a 96-well format
Jeremy Guo et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Share Paper
